These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 8635500)

  • 1. Plasminogen activator inhibitor type-2 (PAI-2) in human keratinocytes regulates pericellular urokinase-type plasminogen activator.
    Reinartz J; Schaefer B; Bechtel MJ; Kramer MD
    Exp Cell Res; 1996 Feb; 223(1):91-101. PubMed ID: 8635500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The receptor for urokinase-type plasminogen activator of a human keratinocyte line (HaCaT).
    Reinartz J; Link J; Todd RF; Kramer MD
    Exp Cell Res; 1994 Oct; 214(2):486-98. PubMed ID: 7925643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of urokinase-type plasminogen activator (uPA), its receptor (uPA-R), and inhibitor type-2 (PAI-2) during differentiation of keratinocytes in an organotypic coculture system.
    Schaefer BM; Stark HJ; Fusenig NE; Todd RF; Kramer MD
    Exp Cell Res; 1995 Oct; 220(2):415-23. PubMed ID: 7556451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium modulates the expression of urokinase plasminogen activator and plasminogen activator inhibitor 2 by human keratinocytes.
    Lyons-Giordano B; Lazarus GS
    Exp Dermatol; 1994 Apr; 3(2):85-8. PubMed ID: 7921656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of cell-surface-associated plasminogen activation in cultured keratinocytes by interleukin-1 beta and tumor necrosis factor-alpha.
    Bechtel MJ; Reinartz J; Rox JM; Inndorf S; Schaefer BM; Kramer MD
    Exp Cell Res; 1996 Mar; 223(2):395-404. PubMed ID: 8601416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of keratinocyte proliferation by plasminogen activator inhibitor-2.
    Hibino T; Matsuda Y; Takahashi T; Goetinck PF
    J Invest Dermatol; 1999 Jan; 112(1):85-90. PubMed ID: 9886269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence of a non-conventional role for the urokinase tripartite complex (uPAR/uPA/PAI-1) in myogenic cell fusion.
    Bonavaud S; Charrière-Bertrand C; Rey C; Leibovitch MP; Pedersen N; Frisdal E; Planus E; Blasi F; Gherardi R; Barlovatz-Meimon G
    J Cell Sci; 1997 May; 110 ( Pt 9)():1083-9. PubMed ID: 9175704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and release of plasminogen activators, their inhibitors and receptor by human tumor cell lines.
    Buø L; Bjørnland K; Karlsrud TS; Kvale D; Kjønniksen I; Fodstad O; Brandtzaeg P; Johansen HT; Aasen AO
    Anticancer Res; 1994; 14(6B):2445-51. PubMed ID: 7872665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasminogen activation in bullous pemphigoid immunohistology reveals urokinase type plasminogen activator, its receptor and plasminogen activator inhibitor type-2 in lesional epidermis.
    Schaefer BM; Jaeger C; Drepper E; Kramer MD
    Autoimmunity; 1996; 23(3):155-64. PubMed ID: 8879451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydrocortisone regulates the dynamics of plasminogen activator and plasminogen activator inhibitor expression in cultured murine keratinocytes.
    Bator JM; Cohen RL; Chambers DA
    Exp Cell Res; 1998 Jul; 242(1):110-9. PubMed ID: 9665808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dispase-mediated basal detachment of cultured keratinocytes induces urokinase-type plasminogen activator (uPA) and its receptor (uPA-R, CD87).
    Schaefer BM; Reinartz J; Bechtel MJ; Inndorf S; Lang E; Kramer MD
    Exp Cell Res; 1996 Nov; 228(2):246-53. PubMed ID: 8912717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Introduction of an RRHR motif into chicken urokinase-type plasminogen activator (ch-uPA) confers sensitivity to plasminogen activator inhibitor (PAI)-1 and PAI-2 and allows ch-uPA-mediated extracellular matrix degradation to be controlled by PAI-1.
    Sipley JD; Alexander DS; Testa JE; Quigley JP
    Proc Natl Acad Sci U S A; 1997 Apr; 94(7):2933-8. PubMed ID: 9096324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandin E2 regulates production of plasminogen activator isoenzymes, urokinase receptor, and plasminogen activator inhibitor-1 in primary cultures of rat calvarial osteoblasts.
    Allan EH; Martin TJ
    J Cell Physiol; 1995 Dec; 165(3):521-9. PubMed ID: 7593231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasminogen activator inhibitor type 2 (PAI-2) is present in normal human conjunctiva.
    Massaro-Giordano M; Marshall CM; Lavker RM; Jensen PJ; Risse Marsh BC
    J Cell Physiol; 2005 Nov; 205(2):295-301. PubMed ID: 15887231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasminogen activator inhibitor type-2 in the lesional epidermis of lupus erythematosus.
    Bechtel MJ; Schaefer BM; Kramer MD
    Br J Dermatol; 1996 Mar; 134(3):411-9. PubMed ID: 8731662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasminogen activator system in pemphigus vulgaris.
    Schaefer BM; Jaeger CJ; Kramer MD
    Br J Dermatol; 1996 Nov; 135(5):726-32. PubMed ID: 8977672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasminogen activators augment endothelial cell organization in vitro by two distinct pathways.
    Schnaper HW; Barnathan ES; Mazar A; Maheshwari S; Ellis S; Cortez SL; Baricos WH; Kleinman HK
    J Cell Physiol; 1995 Oct; 165(1):107-18. PubMed ID: 7559792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of the urokinase-type plasminogen activator, and its inhibitors and receptor in breast cancer patients.
    Borstnar S; Vrhovec I; Svetic B; Cufer T
    Clin Breast Cancer; 2002 Jun; 3(2):138-46. PubMed ID: 12123538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topological localization of plasminogen activator inhibitor type 2.
    Liew MA; McPhun V; Baker MS
    Cytometry; 2000 May; 40(1):32-41. PubMed ID: 10754515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The THP-1 cell line is a urokinase-secreting mononuclear phagocyte with a novel defect in the production of plasminogen activator inhibitor-2.
    Gross TJ; Sitrin RG
    J Immunol; 1990 Mar; 144(5):1873-9. PubMed ID: 2307845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.